The Zhitong Finance App learned that after being previously opposed by the US Food and Drug Administration (FDA), the influenza vaccine mFlusiva developed by Moderna (MRNA.US) was finally approved for marketing. This is certainly a major victory for the company.

The Zhitong Finance App learned that after being previously opposed by the US Food and Drug Administration (FDA), the influenza vaccine mFlusiva developed by Moderna (MRNA.US) was finally approved for marketing. This is certainly a major victory for the company.